Janice L Bilby, MD | |
701 E County Line Rd, Suite 204, Greenwood, IN 46143-1072 | |
(317) 882-0535 | |
(317) 882-0173 |
Full Name | Janice L Bilby |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 701 E County Line Rd, Greenwood, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528014396 | NPI | - | NPPES |
100074050 | Medicaid | IN | |
000000312875 | Other | IN | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 01032228A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Janice L Bilby, MD 701 E County Line Rd, Suite 204, Greenwood, IN 46143-1072 Ph: (317) 882-0535 | Janice L Bilby, MD 701 E County Line Rd, Suite 204, Greenwood, IN 46143-1072 Ph: (317) 882-0535 |
News Archive
Young adults and their parents eager to take advantage of a new law that will allow parents of children up to age 26 to keep their children on their health plans are facing obstacles in learning even exactly when they'll be eligible.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a Phase IIb trial in adult lung transplant patients with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. RSV infection in lung transplant patients represents an important unmet medical need; the condition is associated with significant morbidity, including the development of acute lung transplant rejection in 10% to 20% of infected patients.
The cost of implementing an innovative quality improvement program that helps colorectal surgery patients recover faster is more than offset by savings from their reduced lengths of stay at hospitals of any size.
Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
› Verified 6 days ago
Dr. Elise Rose Laroche, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 747 E County Line Rd Ste D, Greenwood, IN 46143 Phone: 317-888-9669 Fax: 317-885-7966 | |
Brittany Y. Simpson, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 533 E County Line Rd, Greenwood, IN 46143 Phone: 317-957-9050 | |
Dr. Charles L Richert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 S State Road 135 Ste 220, Greenwood, IN 46143 Phone: 317-621-2290 | |
Dr. Douglas K Bullington, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3000 S State Road 135, Suite 200, Greenwood, IN 46143 Phone: 317-535-1876 Fax: 317-535-5049 | |
Shelley R Stiner, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 N State Road 135, Ste 103, Greenwood, IN 46142 Phone: 317-550-4510 Fax: 317-886-4550 | |
Ehab Wanas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Sarah Ann Beeson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 S State Road 135 Ste 200, Greenwood, IN 46143 Phone: 317-535-1876 |